FIELD: medicine, pharmacy. SUBSTANCE: invention relates to method for preparing the pharmaceutical composition used for treatment of morbid states mediated by leukotriene antagonists, to the pharmaceutical composition used for treatment of morbid states mediated by leukotriene antagonists comprising great number of beads containing amorphous zafirlukast and to methods of treatment of the above indicated morbid states. Invention provides preparing stable beads where physical forms of zafirlukast don't convert each to other in the process of their preparing and processing the composition (including under conditions of elevated temperatures and humidity). EFFECT: improved methods of preparing and treatment, valuable properties of composition. 10 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
SYSTEMS OF MEDICATION DELIVERY, INCLUDING SOLID SOLUTIONS OF WEAK-BASE MEDICATIONS | 2007 |
|
RU2434630C2 |
THERAPEUTIC TREATMENT | 2004 |
|
RU2358737C2 |
SOLID MOLECULAR DISPERSION | 2012 |
|
RU2600816C2 |
SYSTEMS OF MEDICATION DELIVERY, CONTAINING WEAK-BASE MEDICATIONS AND ORGANIC ACIDS | 2007 |
|
RU2428176C2 |
FORM OF PROLONGED VENLAFAXINE HYDROCHLORIDE LIBERATION | 2004 |
|
RU2340331C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING AMINO COMPOUND | 2012 |
|
RU2607480C2 |
PROLONGED-RELEASE ORAL PHARMACEUTICAL MEDICINAL FORM | 1998 |
|
RU2214232C2 |
SYSTEMS OF DELIVERING MEDICAL SUBSTANCES, INCLUDING WEAKLY BASIC MEDICINAL SUBSTANCES AND ORGANIC ACIDS | 2009 |
|
RU2504362C2 |
PER ORALLY DECOMPOSING TABLET COMPOSITIONS, CONTAINING COMBINATIONS OF NON-OPIATE ANALGESICS | 2010 |
|
RU2567032C2 |
COMPOSITIONS OF ORALLY DISPERSIBLE TABLETS CONTAINING COMBINATIONS OF HIGH- AND LOW-DOSE THERAPEUTIC AGENTS | 2010 |
|
RU2554740C2 |
Authors
Dates
2003-05-27—Published
1998-12-15—Filed